← Open Payments lookup

RACQUEL GRADNEY: Open Payments

NPI 1699253401 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$629 in 29 payments from 12 companies in 2025. Trend: 2023 $416 · 2024 $784 · 2025 $629

Food & beverage: $629
CompanyPaymentsAmount
Novo Nordisk Inc5$190
Lilly USA, LLC4$76
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$70
Axsome Therapeutics, Inc.3$67
Phathom Pharmaceuticals, Inc.5$51
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$48
Takeda Pharmaceuticals U.S.A., Inc.2$38
AstraZeneca Pharmaceuticals LP1$22
ABBVIE INC.1$20
Boehringer Ingelheim Pharmaceuticals, Inc.1$17

Products named: Ozempic, MOUNJARO, CAPLYTA, Auvelity, VOQUEZNA, XIFAXAN, TRINTELLIX, FARXIGA.

Industry payments across LA — which companies pay providers there.